(Q35041117)

English

Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

0 references

juvenile rheumatoid arthritis

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

Yuliya Lokhnygina

3

object named as

Yuliya Lokhnygina

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Stacey E. Tarvin

13

object named as

Stacey E Tarvin

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Norman T Ilowite

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Kristi Prather

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Laura E Schanberg

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Melissa Elder

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Diana Milojevic

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

James W Verbsky

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Steven J Spalding

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Yukiko Kimura

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Lisa F Imundo

10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Marilynn G Punaro

11

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

David D Sherry

12

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Lawrence S Zemel

14

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

James D Birmingham

15

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Beth S Gottlieb

16

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Michael L Miller

17

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Kathleen O'Neil

18

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Natasha M Ruth

19

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Carol A Wallace

20

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Nora G Singer

21

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Christy I Sandborg

22

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

1 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2570-2579

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Alternative activation in systemic juvenile idiopathic arthritis monocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Rilonacept (arcalyst), an interleukin-1 trap for the treatment of cryopyrin-associated periodic syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Anakinra for systemic juvenile arthritis: the Rocky Mountain experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Comprehensive association study of genetic variants in the IL-1 gene family in systemic juvenile idiopathic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Cytokine traps: multi-component, high-affinity blockers of cytokine action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

A Multiple Testing Procedure for Clinical Trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

8 July 2018

Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study.

1 reference

https://api.crossref.org/works/10.1002%2FART.38699

21 January 2018

The randomized placebo-phase design for clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FART.38699

21 January 2018

Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4314719

25 October 2018

Preliminary definition of improvement in juvenile arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24839206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24839206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macrophage activation syndrome in systemic juvenile rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24839206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Candidate early predictors for progression to joint damage in systemic juvenile idiopathic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24839206

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/ART.38699

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35041117&oldid=1599233841"